These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2442112)

  • 1. Interferons in the treatment of multiple myeloma.
    Ohno R
    Int J Cancer Suppl; 1987; 1():14-20. PubMed ID: 2442112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenburg L; Machover D; Ribaud P; De Vassal F; Horosezewicz JS
    Biomed Pharmacother; 1982 Jan; 36(1):55-9. PubMed ID: 6181822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; De Vassal F; Horoszewicz JS
    Anticancer Res; 1982; 2(1-2):63-6. PubMed ID: 6180675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
    Gutterman JU; Blumenschein GR; Alexanian R; Yap HY; Buzdar AU; Cabanillas F; Hortobagyi GN; Hersh EM; Rasmussen SL; Harmon M; Kramer M; Pestka S
    Ann Intern Med; 1980 Sep; 93(3):399-406. PubMed ID: 6159812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple myeloma with recombinant interferon alfa-2a.
    Ohno R; Kimura K
    Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bence-Jones myeloma with pleural effusion: response to alpha-interferon and combined chemotherapy.
    Makino S; Yamahara S; Nagake Y; Kamura J
    Intern Med; 1992 May; 31(5):617-21. PubMed ID: 1504423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.
    Solomon A
    J Clin Invest; 1978 Jan; 61(1):97-108. PubMed ID: 618916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons in the treatment of multiple myeloma.
    Cooper MR
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.
    Ahre A; Björkholm M; Mellstedt H; Brenning G; Engstedt L; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Järnmark M
    Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
    Wagstaff J; Scarffe JH; Crowther D
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
    [No Abstract]   [Full Text] [Related]  

  • 12. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
    Solomon A; McLaughlin CL; Capra JD
    J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
    Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon.
    Ohno R; Kodera Y; Ogura M; Murase T; Emi N; Okumura M; Morishita Y; Nagura E; Minami S; Morishima Y
    Cancer Chemother Pharmacol; 1985; 14(1):34-7. PubMed ID: 3917376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Semin Oncol; 1986 Sep; 13(3):334-40. PubMed ID: 2429367
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multiple myeloma with recombinant alpha-interferon.
    Quesada JR; Alexanian R; Hawkins M; Barlogie B; Borden E; Itri L; Gutterman JU
    Blood; 1986 Feb; 67(2):275-8. PubMed ID: 3942826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.
    Ann Intern Med; 1996 Jan; 124(2):212-22. PubMed ID: 8533996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy in multiple myeloma.
    Ideström K; Cantell K; Killander D; Nilsson K; Strander H; Willems J
    Acta Med Scand; 1979; 205(3):149-54. PubMed ID: 106625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
    Naldini A; Fleischmann WR
    J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.
    Trippoli S; Messori A; Becagli P; Alterini R; Tendi E
    Oncol Rep; 1998; 5(6):1475-82. PubMed ID: 9769391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.